UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 31

Sortiert nach

Clinical application of antidepressant pharmacogenetics: Considerations for the design of future studies

Neuroscience letters, 2020-05, Vol.726, p.133651-133651, Article 133651

2020

Link zum Volltext

Verfügbarkeit prüfen

Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy

European neuropsychopharmacology, 2012-04, Vol.22 (4), p.239-258

2012

Link zum Volltext

Verfügbarkeit prüfen

Genetics of long-term treatment outcome in bipolar disorder

Progress in neuro-psychopharmacology & biological psychiatry, 2016-02, Vol.65, p.17-24

2016

Link zum Volltext

Verfügbarkeit prüfen

Pharmacogenetic tests to guide drug treatment in depression: Comparison of the available testing kits and clinical trials

Progress in neuro-psychopharmacology & biological psychiatry, 2018-08, Vol.86, p.36-44

2018

Link zum Volltext

Verfügbarkeit prüfen

Novel antipsychotics specificity profile: A clinically oriented review of lurasidone, brexpiprazole, cariprazine and lumateperone

European neuropsychopharmacology, 2019-09, Vol.29 (9), p.971-985

2019

Link zum Volltext

Verfügbarkeit prüfen

Pharmacogenetics in major depression: A comprehensive meta-analysis

Progress in neuro-psychopharmacology & biological psychiatry, 2013-08, Vol.45, p.183-194

2013

Link zum Volltext

Verfügbarkeit prüfen

Clinical insights into the cross-link between mood disorders and type 2 diabetes: A review of longitudinal studies and Mendelian randomisation analyses

Neuroscience and biobehavioral reviews, 2023-09, Vol.152, p.105298-105298, Article 105298

2023

Link zum Volltext

Verfügbarkeit prüfen

Polygenic risk scores for mood and related disorders and environmental factors: Interaction effects on wellbeing in the UK biobank

Progress in neuro-psychopharmacology & biological psychiatry, 2024-06, Vol.132, p.110972-110972, Article 110972

2024

Link zum Volltext

Verfügbarkeit prüfen

Stratification of individuals with lifetime depression and low wellbeing in the UK Biobank

Journal of affective disorders, 2022-10, Vol.314, p.281-292

2022

Link zum Volltext

Verfügbarkeit prüfen

Association between CANCA1C gene rs1034936 polymorphism and alcohol dependence in bipolar disorder

Journal of affective disorders, 2020-01, Vol.261, p.181-186

2020

Link zum Volltext

Verfügbarkeit prüfen

Early antidepressant efficacy modulation by glutamatergic gene variants in the STARD

European neuropsychopharmacology, 2013-07, Vol.23 (7), p.612-621

2013

Link zum Volltext

Verfügbarkeit prüfen

Genetic basis of psychopathological dimensions shared between schizophrenia and bipolar disorder

Progress in neuro-psychopharmacology & biological psychiatry, 2019-03, Vol.89, p.23-29

2019

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness of genetic and clinical predictors for choosing combined psychotherapy and pharmacotherapy in major depression

Journal of affective disorders, 2021-01, Vol.279, p.722-729

2021

Link zum Volltext

Verfügbarkeit prüfen

Add-on benzodiazepine treatment in patients with major depressive disorder – results from a European cross-sectional multicenter study

European neuropsychopharmacology, 2020-12, Vol.41, p.70-80

2020

Link zum Volltext

Verfügbarkeit prüfen

Melancholic features in major depression – a European multicenter study

Progress in neuro-psychopharmacology & biological psychiatry, 2021-08, Vol.110, p.110285-110285, Article 110285

2021

Link zum Volltext

Verfügbarkeit prüfen

Real-world characteristics of European patients receiving SNRIs as first-line treatment for major depressive disorder

Journal of affective disorders, 2023-07, Vol.332, p.105-114

2023

Link zum Volltext

Verfügbarkeit prüfen

Evidence on sociodemographic and clinical correlates of antidepressant combination or augmentation with second-generation antipsychotics in major depressive disorder

Progress in neuro-psychopharmacology & biological psychiatry, 2022-03, Vol.114, p.110480-110480, Article 110480

2022

Link zum Volltext

Verfügbarkeit prüfen

Melancholic features and typical neurovegetative symptoms of major depressive disorder show specific polygenic patterns

Journal of affective disorders, 2023-01, Vol.320, p.534-543

2023

Link zum Volltext

Verfügbarkeit prüfen

Drug repositioning for treatment-resistant depression: Hypotheses from a pharmacogenomic study

Progress in neuro-psychopharmacology & biological psychiatry, 2021-01, Vol.104, p.110050, Article 110050

2021

Link zum Volltext

Verfügbarkeit prüfen

Multi-omics data integration methods and their applications in psychiatric disorders

European neuropsychopharmacology, 2023-04, Vol.69, p.26-46

2023

Link zum Volltext

Verfügbarkeit prüfen

Pregabalin augmentation of antidepressants in major depression - results from a European multicenter study

Journal of affective disorders, 2022-01, Vol.296, p.485-492

2022

Link zum Volltext

Verfügbarkeit prüfen

The link between cognition and somatic conditions related to insulin resistance in the UK Biobank study cohort: a systematic review

Neuroscience and biobehavioral reviews, 2022-12, Vol.143, p.104927, Article 104927

2022

Link zum Volltext

Verfügbarkeit prüfen

A meta-analysis of polygenic risk scores for mood disorders, neuroticism, and schizophrenia in antidepressant response

European neuropsychopharmacology, 2022-02, Vol.55, p.86-95

2022

Link zum Volltext

Verfügbarkeit prüfen

The Role of Relationship Status in Major Depressive Disorder - Results of the European Group for the Study of Resistant Depression

Journal of affective disorders, 2021-05, Vol.286, p.149-157

2021

Link zum Volltext

Verfügbarkeit prüfen

A novel mutation in the N-terminal acting-binding domain of Filamin C protein causing a distal myofibrillar myopathy

Journal of the neurological sciences, 2019-03, Vol.398, p.75-78

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 31

Suche als RSS-Feed

Aktive Filter

KollektionElsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)

ThemaNeurosciences & Neurology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(31)

Sprache

Englisch
(31)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(31)
Science & Technology
(31)
Clinical Neurology
(25)
Psychiatry
(24)
Humans
(23)
Neurosciences
(22)
Pharmacology & Pharmacy
(15)
Depressive Disorder, Major - Drug Therapy
(11)
Male
(11)
Antidepressive Agents - Therapeutic Use
(10)
Depression
(9)
Depressive Disorder, Major - Genetics
(9)
Adult
(8)
Antidepressants
(8)
Female
(8)
Major Depressive Disorder
(8)
Treatment Response
(7)
Treatment Outcome
(6)
Antidepressant
(5)

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

Ingenta
(31)
Elsevier ScienceDirect Journals Complete
(31)
MEDLINE
(25)
Journals@Ovid Full Text
(10)
IngentaConnect Journals
(1)

Zeitschrift / Serie

2 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Clinical application of antidepressant pharmacogenetics: Considerations for the design of future studies

Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy

Genetics of long-term treatment outcome in bipolar disorder

Pharmacogenetic tests to guide drug treatment in depression: Comparison of the available testing kits and clinical trials

Novel antipsychotics specificity profile: A clinically oriented review of lurasidone, brexpiprazole, cariprazine and lumateperone

Pharmacogenetics in major depression: A comprehensive meta-analysis

Clinical insights into the cross-link between mood disorders and type 2 diabetes: A review of longitudinal studies and Mendelian randomisation analyses

Polygenic risk scores for mood and related disorders and environmental factors: Interaction effects on wellbeing in the UK biobank

Stratification of individuals with lifetime depression and low wellbeing in the UK Biobank

Association between CANCA1C gene rs1034936 polymorphism and alcohol dependence in bipolar disorder

Early antidepressant efficacy modulation by glutamatergic gene variants in the STARD

Genetic basis of psychopathological dimensions shared between schizophrenia and bipolar disorder

Cost-effectiveness of genetic and clinical predictors for choosing combined psychotherapy and pharmacotherapy in major depression

Add-on benzodiazepine treatment in patients with major depressive disorder – results from a European cross-sectional multicenter study

Melancholic features in major depression – a European multicenter study

Real-world characteristics of European patients receiving SNRIs as first-line treatment for major depressive disorder

Evidence on sociodemographic and clinical correlates of antidepressant combination or augmentation with second-generation antipsychotics in major depressive disorder

Melancholic features and typical neurovegetative symptoms of major depressive disorder show specific polygenic patterns

Drug repositioning for treatment-resistant depression: Hypotheses from a pharmacogenomic study

Multi-omics data integration methods and their applications in psychiatric disorders

Pregabalin augmentation of antidepressants in major depression - results from a European multicenter study

The link between cognition and somatic conditions related to insulin resistance in the UK Biobank study cohort: a systematic review

A meta-analysis of polygenic risk scores for mood disorders, neuroticism, and schizophrenia in antidepressant response

The Role of Relationship Status in Major Depressive Disorder - Results of the European Group for the Study of Resistant Depression

A novel mutation in the N-terminal acting-binding domain of Filamin C protein causing a distal myofibrillar myopathy

Aktive Filter

Suchergebnisse filtern